Sarah James
Stock Analyst at Cantor Fitzgerald
(1.99)
# 3,152
Out of 5,090 analysts
300
Total ratings
35.56%
Success rate
-7.23%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Neutral | $22 → $17 | $15.28 | +11.26% | 18 | Dec 3, 2025 | |
| CNC Centene | Maintains: Neutral | $38 → $41 | $38.36 | +6.90% | 16 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Overweight | $78 → $95 | $75.21 | +26.32% | 16 | Oct 30, 2025 | |
| UHS Universal Health Services | Maintains: Neutral | $227 → $250 | $230.40 | +8.51% | 27 | Oct 29, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $190 → $245 | $210.92 | +16.16% | 23 | Oct 29, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $210 → $180 | $151.18 | +19.06% | 14 | Oct 24, 2025 | |
| SGRY Surgery Partners | Reiterates: Overweight | $36 | $17.18 | +109.61% | 13 | Oct 7, 2025 | |
| HCAT Health Catalyst | Reiterates: Neutral | $4 | $2.62 | +52.67% | 8 | Oct 7, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $444 | $484.21 | -8.30% | 21 | Oct 7, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $440 | $331.30 | +32.81% | 18 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $265.15 | +37.66% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $23.97 | +16.81% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $290 | $258.22 | +12.31% | 21 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $330.66 | +46.68% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $23.06 | +25.76% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $3.53 | +325.53% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $1.05 | +376.19% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $7.64 | +30.89% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $118.34 | +12.39% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $27.32 | +53.73% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $5.04 | -0.79% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $9.33 | -46.41% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $19.54 | +7.47% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $78.28 | -50.18% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $73.67 | +161.98% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.51 | - | 2 | Mar 1, 2017 |
Acadia Healthcare Company
Dec 3, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $15.28
Upside: +11.26%
Centene
Oct 30, 2025
Maintains: Neutral
Price Target: $38 → $41
Current: $38.36
Upside: +6.90%
CVS Health
Oct 30, 2025
Maintains: Overweight
Price Target: $78 → $95
Current: $75.21
Upside: +26.32%
Universal Health Services
Oct 29, 2025
Maintains: Neutral
Price Target: $227 → $250
Current: $230.40
Upside: +8.51%
Tenet Healthcare
Oct 29, 2025
Maintains: Overweight
Price Target: $190 → $245
Current: $210.92
Upside: +16.16%
Molina Healthcare
Oct 24, 2025
Maintains: Neutral
Price Target: $210 → $180
Current: $151.18
Upside: +19.06%
Surgery Partners
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $17.18
Upside: +109.61%
Health Catalyst
Oct 7, 2025
Reiterates: Neutral
Price Target: $4
Current: $2.62
Upside: +52.67%
HCA Healthcare
Oct 7, 2025
Reiterates: Overweight
Price Target: $444
Current: $484.21
Upside: -8.30%
UnitedHealth Group
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $331.30
Upside: +32.81%
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $265.15
Upside: +37.66%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $23.97
Upside: +16.81%
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $258.22
Upside: +12.31%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $330.66
Upside: +46.68%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $23.06
Upside: +25.76%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $3.53
Upside: +325.53%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $1.05
Upside: +376.19%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $7.64
Upside: +30.89%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $118.34
Upside: +12.39%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $27.32
Upside: +53.73%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $5.04
Upside: -0.79%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $9.33
Upside: -46.41%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $19.54
Upside: +7.47%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $78.28
Upside: -50.18%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $73.67
Upside: +161.98%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.51
Upside: -